# InTandem Capital
Firm at a glance
InTandem Capital is a platform-focused private equity firm headquartered in New York, NY [S1].
What they buy
Based on publicly disclosed transactions, InTandem Capital concentrates its investment activity in healthcare services [S2][S3][S4]. The firm’s recent deal flow suggests a focus on businesses that serve the healthcare ecosystem, particularly companies providing cost containment, revenue cycle management, and clinical research services. All three transactions completed in the past 24 months fall within the healthcare sector, indicating a deliberate sector specialization strategy.
Portfolio
Public records identify the following portfolio companies:
**The Phia Group** (platform investment, acquired December 2025), a provider of healthcare cost containment services [S2].
**Healthfuse** (acquired January 2025), which specializes in revenue cycle vendor management for healthcare organizations [S3].
**Clinilabs** (acquired April 2025), a clinical research services provider [S4].
Recent activity (last 24 months)
* Completed investment in The Phia Group, a healthcare cost containment leader, in December 2025 [S2]
* Acquired Healthfuse, a revenue cycle vendor management platform, in January 2025 [S3]
* Backed Clinilabs, a clinical research services company, in April 2025 [S4]
How this firm fits a seller
InTandem Capital appears positioned for healthcare services business owners seeking a buyer with demonstrated sector expertise and an active acquisition program. The firm’s three transactions within a 12-month window suggest operational capacity to close deals efficiently. Sellers in adjacent healthcare verticals (medical billing, healthcare IT, clinical services) may find alignment with the firm’s existing portfolio footprint, though owners should verify current investment criteria directly with the firm.
Sources
[S1] https://intandemcapital.com (as of 2025-01-10)
[S2] https://www.businesswire.com/news/home/20251202551021/en/InTandem-Capital-Completes-Investment-in-The-Phia-Group-a-Leader-in-Healthcare-Cost-Containment (as of 2025-12-02)
[S3] https://www.businesswire.com/news/home/20250116561206/en/InTandem-Capital-Completes-Strategic-Investment-in-Healthfuse-the-Leader-in-Revenue-Cycle-Vendor-Management (as of 2025-01-16)
[S4] https://www.mpo-mag.com/breaking-news/intandem-capital-partners-backs-clinilabs/ (as of 2025-04-08)
Frequently asked questions
Does InTandem Capital buy Healthcare Services businesses?
Yes, healthcare services represents the firm’s primary investment focus based on publicly available transaction records. All three disclosed acquisitions from 2025 fall within healthcare services subsectors, including cost containment, revenue cycle management, and clinical research [S2][S3][S4].
What companies has InTandem Capital acquired recently?
Recent acquisitions include The Phia Group (healthcare cost containment), Healthfuse (revenue cycle vendor management), and Clinilabs (clinical research services), all completed between January and December 2025 [S2][S3][S4].
Where is InTandem Capital based and how big is the firm?
The firm maintains its headquarters at One Vanderbilt Avenue Suite 2400 in New York, NY [S1]. Fund size and assets under management have not been publicly disclosed as of January 2025.
Is InTandem Capital still actively acquiring?
Yes, the firm completed its most recent disclosed transaction in December 2025 with the acquisition of The Phia Group [S2], indicating ongoing investment activity as of the end of 2025.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.